Back
ESC2025 Premium Access

Microalbuminuria in heart transplant recipients -insights from the randomized trial dapagliflozin for renal protection in heart transplant recipients (DAPARHT)

Session: Heart transplantation: risks, markers, and outcomes
Topic: Heart Transplantation
Speaker: Doctor S. Holmen (Oslo, NO)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Stine Holmen

Oslo University Hospital Rikshospitalet, Oslo (Norway)
0 follower

6 more presentations in this session

Donation after circulatory death in a European ultraperipheral and multi-insular region.

Speaker: Doctor M. Galvan Ruiz (Las Palmas de Gran Canaria, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Lipoprotein (a) levels and cardiac allograft vasculopathy in heart transplant recipients: single centre experience

Speaker: Doctor D. Bacich (Padua, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Methylome-driven regulation of miRNA expression in dilated cardiomyopathy

Speaker: Miss M. Delgado Arija (Valencia, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Identification of novel RNA-sequencing biomarkers for early detection of heart transplantation rejection utilizing machine learning techniques

Speaker: Associate Professor B. Sharif Kashani (Tehran, IR)

Access
Abstract
Slides
Video
Like
Thumbnail

Causes and prognostic implications of hospital admissions following successful heart transplantation

Speaker: Doctor M. Presume (Lisbon, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Heart transplantation: risks, markers, and outcomes

Speakers: Doctor S. Holmen, Doctor M. Galvan Ruiz, Doctor D. Bacich, Miss M. Delgado Arija, Associate Professor B. Sharif Kashani...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources